An Open-Label, Parallel-Group, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delayed-Release Dimethyl Fumarate in Chinese, Japanese, and Caucasian Adult Healthy Volunteers.

被引：0
|
作者：
Tibung, J. T. [1 ]
Nestorov, I. [2 ]
McNeill, M. [3 ]
Li, J. [2 ]
Zhu, B. [2 ]
机构：
[1] Biogen Ltd, Tokyo, Japan
[2] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA
[3] Biogen UK Ltd, Maidenhead, Berks, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-47
引用
收藏
页码：422 / 422
页数：1
相关论文
共 50 条
  • [1] Similar pharmacokinetics of three dosing regimens comprising two oral delayed-release mesalamine formulations in healthy adult volunteers: Randomised, open-label, parallel-group study
    Vande Casteele, Niels
    Jakate, Abhijeet
    McNamee, Brian
    Sandborn, William J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1141 - 1149
  • [2] Gastrointestinal tolerability of delayed-release dimethyl fumarate in a multicenter, open-label study of patients with relapsing multiple sclerosis
    Fox, E. J.
    Vasquez, A.
    Grainger, W.
    Ma, T. S.
    von Hehn, C.
    Walsh, J.
    Li, J.
    Zambrano, J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 205 - 205
  • [3] Pharmacokinetic Properties and Tolerability of Bevirimat and Atazanavir in Healthy Volunteers: An Open-Label, Parallel-Group Study
    Martin, David E.
    Galbraith, Hal
    Schettler, Jared
    Ellis, Corey
    Doto, Judy
    CLINICAL THERAPEUTICS, 2008, 30 (10) : 1794 - 1805
  • [4] A Randomized, Open-Label, Parallel-Group Study to Determine the Pharmacokinetics (PK), Safety and Tolerability of Delayed-Release Mesalamine Tablets in Children and Adolescents with Active Ulcerative Colitis (UC)
    Heyman, Melvin
    Ferry, George
    Aronstein, William
    Ajayi, Funmi
    Balan, Guhan
    Kuzmak, Barbara
    Smith-Hall, Nancy
    Winter, Harland
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S546 - S546
  • [5] Pharmacokinetics and tolerability of sublingual fentanyl in healthy Japanese and Caucasian volunteers: Phase I, open-label single-dose study
    Lorch, U.
    Farrell, F.
    Kilborn, J.
    Tarnaoka, M.
    Derrick, R.
    Howell, J.
    PROCEEDINGS OF THE 13TH INTERNATIONAL PAIN CLINIC CONGRESS: WORLD SOCIETY OF PAIN CLINICIANS, 2008, : 131 - +
  • [6] Pharmacokinetics Of Indacaterol/Mometasone Furoate In Healthy Chinese Volunteers: Results From A Randomized, Open-label, Parallel-group Study
    Liu, Yun
    Cao, Weie
    Wang, Yijun
    Vaidya, Soniya
    Sun, Jian
    Wang, Yingying
    Tillmann, Hanns-Christian
    Qian, Chenyu
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB57 - AB57
  • [7] Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study
    Yuan, Gang
    Chen, Yili
    Li, Li
    Wang, Xin
    Wei, Gang
    Zeng, Jiawei
    Hui, Ai-Min
    Jiang, Yueyun
    Zhao, Han
    Diao, Lei
    Zhou, Yongchun
    Xiao, Yinglian
    Chen, Minhu
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2024, 2024
  • [8] A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS OF A SINGLE DOSE OF DAZODALIBEP IN HEALTHY JAPANESE AND CAUCASIAN PARTICIPANTS
    Der, K.
    Wang, Z.
    Bosoro, L.
    Hewitt, L.
    Wilson, T.
    Huang, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S79 - S79
  • [9] Pharmacokinetics of Pilsicainide Hydrochloride for Injection in Healthy Chinese Volunteers: A Randomized, Parallel-Group, Open-Label, Single-Dose Study
    Qiu, Qi
    Liu, Wenfang
    Li, Jing
    Wei, Yongxiang
    Yang, Kexu
    Suo, Wei
    Wu, Wei
    Du, Haiyan
    Zhang, Yingchao
    Zhao, Guiping
    Zhou, Zijie
    Zheng, Yingming
    Lin, Yang
    CLINICAL THERAPEUTICS, 2014, 36 (02) : 255 - 263
  • [10] An open-label phase 1 study to evaluate the pharmacokinetics of axitinib (AG-013736) in healthy Chinese volunteers
    Chen, Ying
    Jiang, Ji
    Zhang, Jianyan
    Tortorici, Michael
    Pithavala, Yazdi K.
    Lu, Lei
    Ni, Grace
    Hu, Pei
    CANCER RESEARCH, 2010, 70
12345